Inscinstech Overview
- Year Founded
-
2017
- Status
-
Private
- Latest Deal Type
-
Series C
- Investors
-
12
Inscinstech General Information
Description
Developer of biological separation technology for biopharmaceutical CMCs. The company aims to develop environmental monitoring devices and equipment used in bio labs, providing clients with quick chemical analysis and high quality data while reducing lab costs.
Contact Information
Website
www.inscinstech.com.cnCorporate Office
- Building 101, Building 13, No. 998, Pangnan Road
- Jiangling Street, Wujiang District
- Suzhou, Jiangsu 215200
- China
Corporate Office
- Building 101, Building 13, No. 998, Pangnan Road
- Jiangling Street, Wujiang District
- Suzhou, Jiangsu 215200
- China
Inscinstech Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 7. Later Stage VC (Series C) | 21-Jan-2025 | Completed | Generating Revenue | |||
| 6. Later Stage VC | 19-Aug-2024 | Completed | Generating Revenue | |||
| 5. Later Stage VC (Series B1) | 10-Jan-2023 | Completed | Generating Revenue | |||
| 4. Later Stage VC (Series B) | 18-Nov-2022 | Completed | Generating Revenue | |||
| 3. Early Stage VC (Series A1) | 07-Feb-2022 | Completed | Generating Revenue | |||
| 2. Early Stage VC (Series A) | 29-Oct-2021 | $10M | $11.5M | Completed | Generating Revenue | |
| 1. Early Stage VC | 26-Jan-2021 | $1.54M | $1.54M | Completed | Generating Revenue |
Inscinstech Patents
Inscinstech Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20260208144-A1 | Method and apparatus for synthesis reaction between reagent and packing | Pending | 22-Jan-2025 | ||
| WO-2026157194-A1 | Method for causing synthesis reaction between reagent and packing material, and device | Pending | 22-Jan-2025 | ||
| US-20260185617-A1 | Selection valve | Pending | 02-Jan-2025 | ||
| EP-4800274-A1 | Selector valve | Pending | 02-Jan-2025 | ||
| WO-2026144377-A1 | Selector valve | Pending | 02-Jan-2025 | F16K11/0743 |
Inscinstech Investors (12)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| China Merchants Capital | Asset Manager | Minority | ||
| Suzhou Oriza Holdings Corporation | Asset Manager | Minority | ||
| China Merchants Kunlun Capital | Growth/Expansion | Minority | ||
| Qiming Venture Partners | Venture Capital | Minority | ||
| Huaxin Capital | Venture Capital | Minority |
Inscinstech Investments (1)
Inscinstech’s most recent deal was a Early Stage VC with Xingchen Zhiyao. The deal was made on 17-Mar-2023.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Xingchen Zhiyao | 17-Mar-2023 | Early Stage VC | Drug Discovery |
Inscinstech FAQs
-
When was Inscinstech founded?
Inscinstech was founded in 2017.
-
Where is Inscinstech headquartered?
Inscinstech is headquartered in Suzhou, China.
-
What industry is Inscinstech in?
Inscinstech’s primary industry is Other Devices and Supplies.
-
Is Inscinstech a private or public company?
Inscinstech is a Private company.
-
What is Inscinstech’s current revenue?
The current revenue for Inscinstech is .
-
How much funding has Inscinstech raised over time?
Inscinstech has raised $11.5M.
-
Who are Inscinstech’s investors?
China Merchants Capital, Suzhou Oriza Holdings Corporation, China Merchants Kunlun Capital, Qiming Venture Partners, and Huaxin Capital are 5 of 12 investors who have invested in Inscinstech.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process